Paul Nguyen
Brigham and Women's Hospital

Last Updated On 3/5/2024 6:36:09 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.

Employment
No Relationships to Disclose

Leadership
No Relationships to Disclose

Stock and Other Ownership Interests
Company: Volatilyx
Recipient: An Immediate Family Member
Company: Nanocan Therapeutics
Recipient: You
Company: Stratagen Bio
Recipient: You
Company: Reversal Therapeutics
Recipient: You
Company: Telerad Oncology
Recipient: You

Honoraria
No Relationships to Disclose

Consulting or Advisory Role
Company: Bayer
Recipient: You
Company: Blue Earth Diagnostics
Recipient: You
Company: Boston Scientific
Recipient: You
Company: Janssen Oncology
Recipient: You
Company: Myovant Sciences
Recipient: You
Company: Nanocan Therapeutics
Recipient: You
Company: AIQ Solutions
Recipient: You
Company: Novartis
Recipient: You
Company: Theranano
Recipient: You

Speakers' Bureau
No Relationships to Disclose

Research Funding
Company: Astellas Pharma
Recipient: You
Company: Janssen
Recipient: You
Company: Bayer
Recipient: You

Patents, Royalties, Other Intellectual Property
Please describe: Wife has a patent on volatile diagnostics of infections
Recipient: An Immediate Family Member

Expert Testimony
No Relationships to Disclose

Travel, Accommodations, Expenses
No Relationships to Disclose

Other Relationship
No Relationships to Disclose

(OPTIONAL) Uncompensated Relationships
not answered

(OPTIONAL) Open Payments Link
not answered